Browsing Tag
women’s health
7 posts
Why Femasys’ FDA-cleared next-generation FemVue device could reshape non-radiation fertility diagnostics in the U.S.
Find out how Femasys’ FDA-cleared next-generation FemVue device could reshape non-radiation fertility diagnostics and influence the U.S. women’s health market today.
Australia kills Cosette’s Mayne Pharma (ASX: MYX) buyout—citing drug supply risk and sovereignty
Australia blocks Cosette’s $430M bid to acquire Mayne Pharma, citing critical medicine supply risks. Find out what triggered the decision and future implications.
Clairity raises $43m to scale first FDA-authorized AI platform for breast cancer risk prediction
Find out how Clairity’s FDA-authorized AI platform and $43M Series B funding aim to transform breast cancer risk prediction and preventive care.
FDA approval and $12m funding propel Femasys’ FemBloc toward market-ready milestone
Discover how Femasys’ FemBloc advances with FDA clearance and $12 M in funding, propelling its non-surgical birth control toward commercialization.
Why Zepp Health’s acquisition of Wild.AI could reshape wearable tech for women athletes
Zepp Health acquires Wild.AI’s IP to embed hormone-aware coaching into Amazfit wearables, signaling a major shift in women’s performance tech. Find out more.
Replacing diet drinks with water more than doubles type 2 diabetes remission in women, ADA 2025 study shows
A new ADA 2025 study shows that women with type 2 diabetes who replaced diet drinks with water saw 90% remission rates and greater weight loss outcomes.
Cosette Pharmaceuticals to acquire Mayne Pharma in $430m deal, strengthening women’s health and dermatology portfolio
Cosette Pharmaceuticals has announced a definitive agreement to acquire Mayne Pharma Group Limited, a move that will significantly…